Abiopharma

HYPERFINE, INC. (HYPR)

Symbol	HYPR
Name	HYPERFINE, INC.
Sector	HEALTH CARE
Region	North America
Industry	Biotechnology: Electromedical & Electrotherapeutic Apparatus
Address	351 NEW WHITFIELD STREET, GUILFORD, Connecticut, 06437, United States
Telephone	+1 203 458-7100
Fax	—
Email	—
Website	https://www.hyperfine.io
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001833769
Description	Hyperfine Inc is a medical device company that created Swoop, a portable MRI system. It has designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose and treat patients in various clinical settings. Additional info from NASDAQ: Hyperfine Inc is a medical device company that created Swoop, a portable MRI system. It has designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose and treat patients in various clinical settings.

2026-05-12 20:06

(30% Negative) HYPERFINE, INC. (HYPR) Reports Q2 2026 Financial Results

2026-05-12 20:05

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

2026-05-12 17:40

New Form S-3 - Hyperfine, Inc. Filed: 2026-05-12 AccNo: 0001193125-26-219646 Size: 436 KB

2026-05-06 20:05

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

2026-04-29 12:15

Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution

2026-04-28 20:05

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

2026-04-09 12:15

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

2026-04-08 17:13

New Form ARS - Hyperfine, Inc. Filed: 2026-04-08 AccNo: 0001193125-26-147643 Size: 10 MB

2026-04-08 17:12

New Form DEFA14A - Hyperfine, Inc. Filed: 2026-04-08 AccNo: 0001193125-26-147638 Size: 705 KB

2026-04-08 17:10

New Form DEF 14A - Hyperfine, Inc. Filed: 2026-04-08 AccNo: 0001193125-26-147623 Size: 1 MB

No clinical trials found for this company.

No clinical products found for this company.